Stock-Based Compensation

12 Months Ended

Dec. 31, 2020

Share-based Payment Arrangement [Abstract]

Equity Awards

Stock-based compensation, which is generally recognized on a straight-line basis, totaled $22 million, $36 million and $43 million during 2020, 2019 and 2018, respectively. We recognized tax benefits of $5 million, $8 million and $10 million related to stock-based compensation during 2020, 2019 and 2018, respectively.

The following table summarizes RSU, restricted stock and stock option activity:


	RSU or Restricted Stock		Stock Options
	Number	Weighted Average Grant Date Fair Value Per Share	Number	Weighted Average Exercise Price Per Share
Outstanding as of December 31, 2017	933,464	$51.85	5,069,956	$60.08
Granted	603,111	57.88	33,615	58.15
Forfeited or expired	(38,365)	54.07	(352,624)	64.64
Vested/exercised	(513,078)	51.58	(161,562)	44.92
Outstanding as of December 31, 2018	985,132	$53.78	4,589,385	$60.25
Granted	1,356,303	32.68	1,192,108	22.47
Forfeited or expired	(173,604)	39.57	(351,885)	60.56
Vested/exercised	(507,520)	47.72	(48,131)	30.46
Outstanding as of December 31, 2019	1,660,311	$39.88	5,381,477	$52.13
Granted	1,355,975	10.30	975,290	11.06
Forfeited or expired	(114,352)	33.74	(603,835)	59.46
Vested/exercised	(643,340)	42.23	—	—
Outstanding as of December 31, 2020	2,258,594	$21.76	5,752,932	$44.40
Options exercisable as of December 31, 2020			3,784,647	$58.80
Remaining unvested options outstanding and expected to vest			1,948,602	$16.72

Our stock-based plans provide that RSUs and restricted stock may not be sold or transferred until service-based restrictions have lapsed and any performance objectives have been attained. Generally, upon termination of employment, RSUs and restricted stock which have not vested are forfeited. RSUs granted to executives in 2020, 2019 and 2018 generally vest ratably over 3 years. RSUs granted to one executive in 2020 vest over 5 years. RSUs granted to directors in 2020, 2019 and 2018 vested upon grant. RSUs awarded to directors in 2019 and 2018 (as well as one RSU award to a director in 2020) are subject to a post-vest holding period of 3 years. During 2020, 2019 and 2018, compensation expense related to RSUs of $17 million, $32 million and $30 million, respectively, was included in corporate G&A. The fair value of RSUs that vested during 2020, 2019 and 2018 was $5 million, $14 million and $28 million, respectively. The balance of unamortized RSU expense as of December 31, 2020 was $10 million, which is expected to be recognized over a weighted-average period of 1.4 years.

The exercise price of options represents the closing price of our common stock on the date of grant. The options granted in 2020, 2019 and 2018 generally vest over 3 years and expire 10 years after the grant date. Options granted to one executive in 2020 vest over 5 years. Stock option expense during 2020, 2019 and 2018 included in corporate G&A totaled $5 million, $4 million and $4 million, respectively. The aggregate intrinsic value of stock options exercised during 2019 and 2018 was $0.3 million and $2 million, respectively. There were no stock option exercises during 2020. The balance of unamortized stock option expense as of December 31, 2020 was $6 million, which is expected to be recognized over a weighted-average period of 2.2 years.

The grant date fair value of options and other significant assumptions follow:


	January 1 - November 30, 2020		December 31, 2020		January 1 - September 30, 2019		October 1 - December 31, 2019		2018
Weighted average grant date fair value	$4.59		$9.05		$7.99		$6.93		$14.87
Expected life of options (in years)	4.6		7.2		5.6		5.4		5.3
Risk-free interest rate	0.4	%	0.5	%	2.6	%	1.7	%	2.7	%
Expected volatility	64.9	%	60.8	%	33.3	%	46.6	%	28.2	%
Expected annual dividend per share	$0.00		$0.00		$0.84		$0.40		$0.84

The computation of the expected volatility assumption used in the Black-Scholes calculations is based on a 50/50 blend of historical and implied volatility.

Information related to options outstanding as of December 31, 2020 follows:


	Options Outstanding				Options Exercisable
Range of Exercise Prices	Number Outstanding	Weighted Average Remaining Contractual Life (In Years)	Weighted Average Exercise Price Per Share		Number Exercisable	Weighted Average Remaining Contractual Life (In Years)	Weighted Average Exercise Price Per Share
$8.81 - $29.50	2,088,027	9.2	$	17.27	130,947	8.4	$	29.03
$46.07 - $62.50	3,054,457	4.4	56.48		3,043,252	4.4	56.47
$70.76 - $79.19	610,448	2.3	76.77		610,448	2.3	76.77
	5,752,932	5.9	$	44.40	3,784,647	4.2	$	58.80

As of December 31, 2020, options outstanding had an aggregate intrinsic value of $5 million, and there was no intrinsic value for options exercisable.

During 2020, 2019 and 2018, performance-based award units totaling 1,156,365; 350,532; and 206,598, respectively, were awarded to Section 16 officers. These awards generally vest after a period of 3 years and contain annual performance conditions for each of the 3 years of the vesting period. Under GAAP, performance-based awards are not deemed granted until the performance targets have been established. The performance targets for each year are generally established in the first quarter. Accordingly, only one-third of the units awarded in any given year are deemed to be granted each year of the 3 year vesting periods. During 2020, the following units were granted:


	Performance-based Award Units Granted in 2020	Weighted Average Grant Date Fair Value Per Share
2020 Performance Award Plan	385,455	$9.05
2019 Performance Award Plan	116,844	$9.77
2018 Performance Award Plan	68,866	$10.75

For awards granted under the 2020, 2019 and 2018 performance award plans, the number of units are adjusted at the end of each performance period based on achievement of certain performance targets and market conditions, as defined in the award agreements.

Compensation expense of $1 million and $9 million related to performance-based award units was included in corporate G&A in 2019 and 2018, respectively. Compensation expense related to performance-based award units in 2020 was immaterial. The balance of unamortized compensation expense associated with performance-based award units as of December 31, 2020 was less than $0.1 million, which is expected to be recognized over a weighted-average period of 0.2 years.

Liability Awards

We grant SGI awards in the form of stock units, determined by dividing the target amount by the closing price of our common stock at the grant date. Each stock unit represents the right to receive cash equal to the value of one share upon settlement. SGI awards granted to executives vest and become payable at a rate of one-third of the total award each year. Compensation expense of $25 million, $6 million and $6 million related to SGI awards was included in corporate G&A in 2020, 2019 and 2018, respectively. Liabilities associated with SGI awards were $29 million and $8 million as of December 31, 2020 and 2019, respectively.

During 2020, 2019 and 2018, performance-based awards were awarded to non-Section 16 executives and will be settled in cash. Compensation expense of $3 million, $8 million and $10 million related to these performance-based awards was included in corporate G&A in 2020, 2019 and 2018, respectively. Liabilities associated with these awards were $16 million and $14 million as of December 31, 2020 and 2019, respectively.